BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 1918966)

  • 1. Tumor necrosis factor-alpha triggers antitoxoplasmal activity of IFN-gamma primed macrophages.
    Sibley LD; Adams LB; Fukutomi Y; Krahenbuhl JL
    J Immunol; 1991 Oct; 147(7):2340-5. PubMed ID: 1918966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.
    Green SJ; Crawford RM; Hockmeyer JT; Meltzer MS; Nacy CA
    J Immunol; 1990 Dec; 145(12):4290-7. PubMed ID: 2124240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
    Hogan MM; Vogel SN
    J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha.
    Langermans JA; Van der Hulst ME; Nibbering PH; Hiemstra PS; Fransen L; Van Furth R
    J Immunol; 1992 Jan; 148(2):568-74. PubMed ID: 1729374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica.
    Lin JY; Seguin R; Keller K; Chadee K
    Immunology; 1995 Jul; 85(3):400-7. PubMed ID: 7558128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
    Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
    Howard AD; Erickson KL
    Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
    Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
    Bermudez LE; Young LS
    J Immunol; 1988 May; 140(9):3006-13. PubMed ID: 2834450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of protein kinase C during taxol-induced activation of murine peritoneal macrophages.
    Jun CD; Choi BM; Kim HM; Chung HT
    J Immunol; 1995 Jun; 154(12):6541-7. PubMed ID: 7759887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
    Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
    J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic activity and production of toxic nitrogen oxides by macrophages treated with IFN-gamma and monoclonal antibodies against the 73-kDa lipopolysaccharide receptor.
    Green SJ; Chen TY; Crawford RM; Nacy CA; Morrison DC; Meltzer MS
    J Immunol; 1992 Sep; 149(6):2069-75. PubMed ID: 1381395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
    Hori K; Ehrke MJ; Mace K; Mihich E
    Cancer Res; 1987 Nov; 47(22):5868-74. PubMed ID: 3117358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trace levels of bacterial lipopolysaccharide prevent interferon-gamma or tumor necrosis factor-alpha from enhancing mouse peritoneal macrophage respiratory burst capacity.
    Ding AH; Nathan CF
    J Immunol; 1987 Sep; 139(6):1971-7. PubMed ID: 3040860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
    Hori K; Mihich E; Ehrke MJ
    Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-alpha and nitric oxide from macrophages via IFN-gamma induction.
    Xing Z; Zganiacz A; Santosuosso M
    J Leukoc Biol; 2000 Dec; 68(6):897-902. PubMed ID: 11129658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
    Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A
    J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.
    Ding AH; Nathan CF; Stuehr DJ
    J Immunol; 1988 Oct; 141(7):2407-12. PubMed ID: 3139757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide synthase is induced in tumor promoter-sensitive, but not tumor promoter-resistant, JB6 mouse epidermal cells cocultured with interferon-gamma-stimulated RAW 264.7 cells: the role of tumor necrosis factor-alpha.
    Murakami A; Kawabata K; Koshiba T; Gao G; Nakamura Y; Koshimizu K; Ohigashi H
    Cancer Res; 2000 Nov; 60(22):6326-31. PubMed ID: 11103793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway.
    Paulnock DM; Lambert LE
    J Immunol; 1990 Jan; 144(2):765-73. PubMed ID: 2104906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.